SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-008050
Filing Date
2024-05-14
Accepted
2024-05-14 06:41:41
Documents
113
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q jagx-20240331x10q.htm   iXBRL 10-Q 2709520
2 EX-10.3 jagx-20240331xex10d3.htm EX-10.3 18407
3 EX-31.1 jagx-20240331xex31d1.htm EX-31.1 11007
4 EX-31.2 jagx-20240331xex31d2.htm EX-31.2 11006
5 EX-32.1 jagx-20240331xex32d1.htm EX-32.1 6963
6 EX-32.2 jagx-20240331xex32d2.htm EX-32.2 6938
  Complete submission text file 0001558370-24-008050.txt   13981519

Data Files

Seq Description Document Type Size
7 EX-101.SCH jagx-20240331.xsd EX-101.SCH 116436
8 EX-101.CAL jagx-20240331_cal.xml EX-101.CAL 69800
9 EX-101.DEF jagx-20240331_def.xml EX-101.DEF 537333
10 EX-101.LAB jagx-20240331_lab.xml EX-101.LAB 824600
11 EX-101.PRE jagx-20240331_pre.xml EX-101.PRE 733254
117 EXTRACTED XBRL INSTANCE DOCUMENT jagx-20240331x10q_htm.xml XML 2607150
Mailing Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104
Business Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104 415-371-8300
Jaguar Health, Inc. (Filer) CIK: 0001585608 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36714 | Film No.: 24941393
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)